Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Study summary

The purpose of this research is to understand how screening for patient resource needs followed by customized resource matching can improve outcomes for adults with breast, lung or gastrointestinal cancer.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedResource Matching and Usual Care

The study team can explain what participation involves.

Who it may be forBreast Cancer · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 3, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Dana-Farber Cancer Institute

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Dana-Farber Cancer Institute
Interventions being studied: Other: Resource Matching; Other: Usual Care

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Eligible patients will be adults age 18 or older, able to consent, scheduled for a new patient consultation in DFCI BOC, TOP or GCC. To select for patients from demographic groups vulnerable to SDoH needs, two different groups will be eligible to participate.
Group A
BIPOC (Black, Latinx, Native American or Pacific Islander)
LEP Spanish-speaking (As indicated by the EHR)
Low SES (from zip code with median household income \<$32,000/year) OR
Age 70+
Group B
Any one NPIQ response indicating SDoH need
Health literacy/numeracy, Caregiving/relationships, OR Finances

Reasons someone may not be able to joinExclusion criteria

\- Group A and B \-- Patients not continuing care at Dana Farber Cancer Institute

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Dana Farber Cancer InstituteBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 3, 2023. Always confirm current availability with the study team.

View original record ↗